Streetbeat News

Products Services

FTNT

NET

PANW

ZS

Zscaler Inc (NASDAQ:ZS) is set to report Q1 FY2024 earnings with expectations of 49 cents EPS and $474.31 million in revenue. The company focuses on AI-based security enhancements and data protection, with projected 33% YoY revenue growth for Q1 and 27-28% for the full year. Despite a challenging macro environment, Zscaler remains cash flow positive with a 121% net retention rate. Analysts are interested in Zscaler's integrated product initiatives and data protection growth. Consensus analyst ratings are a Buy, with a price target of $188.47. Shares closed higher at $193.09. Peers like Fortinet Inc (NASDAQ:FTNT), Cloudflare Inc (NYSE:NET), and Palo Alto Networks (NASDAQ:PANW) also face macro challenges but are adapting strategies.

Portfolio Pulse from Surbhi Jain

November 27, 2023 | 1:54 pm

AMZN

JFBR

Jeffs' Brands Ltd has launched a new keto gummies product under the Wellution™ brand on the Amazon Marketplace. The product, which is based on green apple cider vinegar, is available in the U.S. in time for the holiday season. Jeffs' Brands, listed as JFBR and JFBRW on NASDAQ, owns approximately 49% of SciSparc Nutraceuticals Inc., the owner of Wellution™. Wellution™, which started in 2019, has a range of natural hemp-based candy supplements and has garnered over 30,000 reviews.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:52 pm

INTC

Intel is set to release its Meteor Lake 'Core Ultra' CPUs, the first AI PC processing platform, on December 14. Supply chains are expecting an increase in demand for PC replacements following the launch.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:50 pm

AAPL

Apple is reportedly planning to launch a new product called Vision Pro, which will come in four variants, including one that is reasonably priced, according to industry sources as reported by DigiTimes.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:49 pm

NCNC

noco-noco Inc. (NASDAQ:NCNC) plans to acquire 51% of Japanese EV manufacturer Assemblepoint for $3.6M via a share swap. The deal, expected to close in Q1 2024, aims to leverage noco-noco's battery technology and Assemblepoint's scalable Smart Bus assembly to address environmental and transportation challenges. The acquisition is anticipated to be accretive to noco-noco's revenue and earnings in 2024 and will support its expansion in the EV market across Asia and the Middle East. The Philippines, a key market, aims to reduce emissions by 75% by 2023, and the partnership will help overcome challenges like lack of charging infrastructure.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:46 pm

ANIX

Anixa Biosciences, Inc. (NASDAQ:ANIX) announced that the European Patent Office intends to grant a patent for its ovarian cancer vaccine technology, which was developed in partnership with Cleveland Clinic. The technology, which targets AMHR2-ED expressed in ovarian cancers, has already been granted a U.S. patent and is being developed with the collaboration of the National Cancer Institute's PREVENT program.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:44 pm

AGLE

Aeglea BioTherapeutics has changed its name to Spyre Therapeutics and will trade under the symbol 'SYRE' starting November 28, 2023. The company appointed Cameron Turtle as CEO and added industry veterans Jeffrey Albers and Laurie Stelzer to its Board of Directors. Spyre is expanding its leadership team to develop therapeutic combinations for IBD, with lead programs SPY001 and SPY002 entering clinical studies in 2024. The company has a financial runway into 2026 with $205 million in cash and equivalents as of September 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:42 pm

IMAX

PATHE CINEMAS and IMAX Corporation have expanded their partnership with an agreement for five new IMAX with Laser systems in Europe, primarily France, and a three-picture slate agreement with PATHE LIVE for distribution across the IMAX network. The deal includes the release of a Filmed for IMAX ballet, 'Swan Lake', by Paris Opera and PATHE LIVE. IMAX continues to perform well in France, matching its highest grossing year at the French box office since 2019. The partnership between PATHE CINEMAS and IMAX dates back to 2010, with 26 locations across Europe and Morocco.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:41 pm

CYRX

Cryoport Inc. (NASDAQ:CYRX) and NIPPON EXPRESS HOLDINGS have formed a strategic partnership to provide global temperature-controlled supply chain services for the life sciences industry. The partnership combines Cryoport's integrated system, including shipping packages and bioservices, with Nippon Express' global logistics network. This collaboration aims to enhance Cryoport's logistics solutions and capabilities to support the life sciences and biopharmaceutical industries.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:40 pm

DRIO

DarioHealth Corp. (NASDAQ:DRIO) has secured a contract to provide its cardiometabolic solution to a national financial and business services company starting January 2024. The solution includes support for diabetes, pre-diabetes, weight management, hypertension, and GLP-1 medication users. Dario's approach combines technology and human support, aiming to improve clinical outcomes through sustained behavior change.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:38 pm